Actively Recruiting

Phase Not Applicable
Age: 18Years - 89Years
All Genders
NCT05591040

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

Led by IRCCS San Camillo, Venezia, Italy · Updated on 2026-03-27

100

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

Sponsors

I

IRCCS San Camillo, Venezia, Italy

Lead Sponsor

O

Ospedale Policlinico San Martino

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia. This study will be a multicentric randomized, single-blind controlled study. The investigators intend to recruit 100 patients who have suffered a stroke and have dysphagia. Fifty patients will undergo training with bio-feedback (experimental group) and the other fifty patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). Our hypothesis, based on the results obtained in some previous studies, is that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength, timing, coordination and efficacy of the swallowing act.

CONDITIONS

Official Title

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

Who Can Participate

Age: 18Years - 89Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • First stroke injury
  • Stroke onset more than six weeks ago
  • Presence of dysphagia
  • Good comprehension (not below PT 53 in Token Test)
  • Good eyesight and hearing, or adequately corrected
Not Eligible

You will not qualify if you...

  • Conditions preventing good electromyographic signal recording (e.g., infection, wound, dermatitis in submandibular area)
  • Severe illnesses affecting patient cooperation (fever, infections, metabolic problems, serious cardiac insufficiency)
  • Serious dystonia or unintentional movements
  • Disorders of consciousness
  • Encephalopathy due to multiple infarcts
  • Inability to sustain the experimental treatment
  • Other neurological diseases such as Parkinson's disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sara Nordio

Venice-Lido, Italy

Actively Recruiting

Loading map...

Research Team

S

Sara Nordio

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here